Grants and Contributions:

Back to search

Title:

Positioning Canadian Innovation on a Global Stage using Ceapro’s Disruptive PGX Platform Technology

Agreement Number:

931526

Agreement Value:

$590,000.00

Agreement Date:

Jul 16, 2019 - Jun 30, 2021

Description:

The Pressurized Gas eXpanded (PGX) Technology is a patented platform technology for the generation of fine-structured, open-porous, water-soluble biopolymer carriers for tailor-made bioactive or drug delivery systems. Ceapro will further develop the patented PGX Technology by upgrading the PGX Demonstration Plant and by scaling up the Ceapro impregnation technology to the demonstration scale to generate novel “impregnated Polymer compleX” (iPX) for use as delivery systems. By conducting studies on the iPX generated and modeling processing and equipment costs, Ceapro will continue to progressively deploy the PGX Technology to generate innovative products into the functional food, cosmetic and drug delivery markets.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Edmonton, Alberta, CA T6E 6W2

Reference Number:

172-2019-2020-Q2-931526

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

887207280

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The total amended value is 240,000 dollars.

Amendment Date

Oct 16, 2020

Recipient's Legal Name:

CEAPRO Inc.

Federal Riding Name:

Edmonton Strathcona

Federal Riding Number:

48019

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

325410

Amendments:

See Amendments